Literature DB >> 22100281

Synergistic activity of sulbactam combined with colistin against colistin-resistant Acinetobacter baumannii.

Marie Kempf, Lamia Djouhri-Bouktab, Jean-Michel Brunel, Didier Raoult, Jean-Marc Rolain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22100281     DOI： 10.1016/j.ijantimicag.2011.10.001

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  11 in total

1.  Molecular mechanisms of sulbactam antibacterial activity and resistance determinants in Acinetobacter baumannii.

Authors:  William F Penwell; Adam B Shapiro; Robert A Giacobbe; Rong-Fang Gu; Ning Gao; Jason Thresher; Robert E McLaughlin; Michael D Huband; Boudewijn L M DeJonge; David E Ehmann; Alita A Miller
Journal:  Antimicrob Agents Chemother       Date:  2015-01-05       Impact factor: 5.191

2.  Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.

Authors:  G Kalin; E Alp; A Akin; R Coskun; M Doganay
Journal:  Infection       Date:  2013-07-05       Impact factor: 3.553

3.  Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii.

Authors:  Marco Falcone; Giusy Tiseo; Alessandro Leonildi; Leonardo Della Sala; Alessandra Vecchione; Simona Barnini; Alessio Farcomeni; Francesco Menichetti
Journal:  Antimicrob Agents Chemother       Date:  2022-03-21       Impact factor: 5.938

4.  New Shuttle Vectors for Gene Cloning and Expression in Multidrug-Resistant Acinetobacter Species.

Authors:  Massimiliano Lucidi; Federica Runci; Giordano Rampioni; Emanuela Frangipani; Livia Leoni; Paolo Visca
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.

Authors:  Louise M Oleksiuk; M Hong Nguyen; Ellen G Press; Cassaundra L Updike; Jessica A O'Hara; Yohei Doi; Cornelius J Clancy; Ryan K Shields
Journal:  Antimicrob Agents Chemother       Date:  2013-11-18       Impact factor: 5.191

6.  In vitro synergism of combinations of colistin with selected antibiotics against colistin-resistant Acinetobacter baumannii.

Authors:  Duygu Percin; Selcan Akyol; Gamze Kalin
Journal:  GMS Hyg Infect Control       Date:  2014-08-19

7.  Colistin versus Colistin Combined with Ampicillin-Sulbactam for Multiresistant Acinetobacter baumannii Ventilator-associated Pneumonia Treatment: An Open-label Prospective Study.

Authors:  Demosthenes Makris; Efi Petinaki; Vasssiliki Tsolaki; Efstratios Manoulakas; Konstantinos Mantzarlis; Olimpia Apostolopoulou; Dimitrios Sfyras; Epaminondas Zakynthinos
Journal:  Indian J Crit Care Med       Date:  2018-02

8.  Multidrug-resistant Acinetobacter baumannii strains with NDM-1: Molecular characterization and in vitro efficacy of meropenem-based combinations.

Authors:  Jingjing Wang; Yongzhong Ning; Shu Li; Yun Wang; Jinhua Liang; Chunming Jin; Hairun Yan; Yongcun Huang
Journal:  Exp Ther Med       Date:  2019-08-20       Impact factor: 2.447

9.  Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients.

Authors:  Ryan K Shields; Cornelius J Clancy; Louise M Gillis; Eun J Kwak; Fernanda P Silveira; Rima C Abdel Massih; Gregory A Eschenauer; Brian A Potoski; M Hong Nguyen
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.

Authors:  Sami Abdellatif; Ahlem Trifi; Foued Daly; Khaoula Mahjoub; Rochdi Nasri; Salah Ben Lakhal
Journal:  Ann Intensive Care       Date:  2016-03-31       Impact factor: 6.925
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.